IL6 and neoplasm: The prosenescent mechanisms inherent throughout most of the cancer treatments may initially obstruct tumor cell proliferation; however, the ensuing inflammation and enhanced lymphangiogenesis as a result of SASP factors such as IL-6, IL-8, VEGFs, and more threatens a broadened invasion through higher cancer cell uptake.